News
SLGL
74.41
+1.24%
0.91
Weekly Report: what happened at SLGL last week (0622-0626)?
Weekly Report · 1d ago
This Nucor Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Benzinga · 5d ago
This Take-Two Interactive Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Benzinga · 5d ago
Sol-Gel Technologies Price Target Announced at $285.00/Share by Mizuho
Dow Jones · 5d ago
Mizuho Initiates Coverage On Sol-Gel Technologies with Outperform Rating, Announces Price Target of $285
Benzinga · 5d ago
Sol-Gel Technologies initiated with an Outperform at Mizuho
TipRanks · 6d ago
Sol-Gel Technologies (SLGL) Initiated with a Buy at Mizuho Securities
TipRanks · 6d ago
Weekly Report: what happened at SLGL last week (0615-0619)?
Weekly Report · 06/22 09:26
Weekly Report: what happened at SLGL last week (0608-0612)?
Weekly Report · 06/15 09:26
Weekly Report: what happened at SLGL last week (0601-0605)?
Weekly Report · 06/08 09:25
Weekly Report: what happened at SLGL last week (0525-0529)?
Weekly Report · 06/01 09:26
Sol-Gel Technologies initiated with a Buy at TD Cowen
TipRanks · 05/29 09:46
Analyst Maintains Buy on Sol-Gel, Citing SGT-610 Progress and Solid Cash Runway with Unchanged $184 Price Target
TipRanks · 05/29 00:15
Sol-Gel Technologies reports Q1 EPS ($1.31) vs. ($3.20) last year
TipRanks · 05/28 13:02
Sol-Gel Technologies Q1 EPS $(1.31) Beats $(1.84) Estimate, Sales $108.000K Miss $900.000K Estimate
Benzinga · 05/28 12:38
Sol-Gel Extends Patidegib IP to 2044 and Bolsters Cash Runway With $33.1 Million Offering
TipRanks · 05/28 12:31
Sol-Gel Technologies reports Q1 results
Seeking Alpha · 05/28 12:28
Sol-Gel Q1 revenue falls sharply on milestone payment impact
Reuters · 05/28 12:15
Sol-Gel Q1 FY26 net loss narrows to $3.7 million; revenue drops to $0.1 million
PUBT · 05/28 12:03
Top Biotech Gainers: AKTX Rallies; GOVX Up On Ebola Concerns; SLGL Awaits Catalysts; CMMB On Watch
NASDAQ · 05/26 07:50
More
Webull provides a variety of real-time SLGL stock news. You can receive the latest news about Sol Gel Tech through multiple platforms. This information may help you make smarter investment decisions.
About SLGL
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.